Study links air pollution and limited green spaces to higher respiratory hospitalization risk

Long-term exposure to air pollution and a lack of access to green spaces increases the risk of hospitalization for respiratory conditions, according to a study presented at the European Respiratory Society (ERS) Congress in Vienna, Austria.

Bristol Myers Squibb’s Abecma recommended for EU approval

Share this article EMA CHMP endorses Bristol Myers Squibb’s Abecma for the treatment of adult multiple myeloma patients in the EU. Credit: Amy Lutz /

January 29, 2024

How to Navigate OTC Cold and Flu Drugs

The cold and flu aisles of pharmacies are bursting with options, though most share a relatively small roster of active ingredients in various combinations. MedPage

October 31, 2024

Subcutaneous Alzheimer’s Drug May Be on the Horizon

A subcutaneous version of the newly approved Alzheimer’s drug lecanemab (Leqembi) may be on the horizon. Weekly subcutaneous lecanemab 100 mg/mL injection appeared to be

October 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.